Brief: Nanoform Received License From Fimea For APIs In Finland
Nov 11 (Reuters) - Nanoform Finland Oyj NANOFH.HE: RECEIVED COMMERCIAL CGMP MANUFACTURING LICENSE FROM FIMEA FOR PRODUCTION AND QUALITY CONTROL OF NANOFORMED SMALL MOLECULE APIS Source text: https://mfn.se/a/nanoform-finland/inside-information-made-public-nanoform-granted-european-commercial-cgmp-manufacturing-license Further company coverage: NANOFH.HE (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nanoform Finland Oyj
See all newsFinland's Nanoform Q2 EBITDA loss narrows on layoffs, cost cuts
Brief: Nanoform Q2 EBITDA EUR -3 Million
Brief: Nanoform Receives Positive Feedback From UK Mhra Scientific Advice Meeting
Finland's Nanoform Q1 revenue rises 45%, EBITDA loss narrows
Brief: Nanoform Finland Targets Cash Burn Below EUR 10 Mln For 2026